Preliminary studies for the development of intranasal nanoemulsion containing CNS agent: emphasizing the utilization of cut and weigh method. (3rd April 2017)
- Record Type:
- Journal Article
- Title:
- Preliminary studies for the development of intranasal nanoemulsion containing CNS agent: emphasizing the utilization of cut and weigh method. (3rd April 2017)
- Main Title:
- Preliminary studies for the development of intranasal nanoemulsion containing CNS agent: emphasizing the utilization of cut and weigh method
- Authors:
- Kumar, Amrish
Jain, Sunil Kumar - Abstract:
- Abstract: Context : The selection of excipients and preformulation strategy plays a vital role for the development of nanoemulsion, due to anatomical and physiological challenges posed by nasal cavity.Objective : This attempt is focused on the selection and optimization of excipients for the development of a nanoemulsion system for intranasal delivery.Materials and methods : Excipients were selected on the basis of solubility of active drug, compatibility interactions and nasal irritancy. Surfactant and co-surfactant combination and their ratio were finalized on the basis of nanoemulsion region obtained from constructed phase diagrams with Capmul MCM as oil phase. A validated cut and weigh method was employed for the optimization of different phase diagrams with respect to nanoemulsion region.Results and discussion : The solubility of drug in Capmul MCM, Labrasol, and Transcutol-P was found to be superior with numeric values of 79.50 ± 1.68 mg/ml, 51.10 ± 1.39 mg/ml, and 36.60 ± 0.85 mg/ml, respectively. On the basis of phase diagram analysis, Labrasol and Transcutol-P in 3:1 ratio provides greater nanoemulsion region of 65.28 ± 0.18%. The validation of cut and weigh method revealed that there was no significant statistical difference ( P > 0.05) with a %RSD value of 2.38 for intersheet variation.Conclusion : The results of validation studies for cut and weigh method suggests that it can be effectively used as an optimization method for the selection of nanoemulsionAbstract: Context : The selection of excipients and preformulation strategy plays a vital role for the development of nanoemulsion, due to anatomical and physiological challenges posed by nasal cavity.Objective : This attempt is focused on the selection and optimization of excipients for the development of a nanoemulsion system for intranasal delivery.Materials and methods : Excipients were selected on the basis of solubility of active drug, compatibility interactions and nasal irritancy. Surfactant and co-surfactant combination and their ratio were finalized on the basis of nanoemulsion region obtained from constructed phase diagrams with Capmul MCM as oil phase. A validated cut and weigh method was employed for the optimization of different phase diagrams with respect to nanoemulsion region.Results and discussion : The solubility of drug in Capmul MCM, Labrasol, and Transcutol-P was found to be superior with numeric values of 79.50 ± 1.68 mg/ml, 51.10 ± 1.39 mg/ml, and 36.60 ± 0.85 mg/ml, respectively. On the basis of phase diagram analysis, Labrasol and Transcutol-P in 3:1 ratio provides greater nanoemulsion region of 65.28 ± 0.18%. The validation of cut and weigh method revealed that there was no significant statistical difference ( P > 0.05) with a %RSD value of 2.38 for intersheet variation.Conclusion : The results of validation studies for cut and weigh method suggests that it can be effectively used as an optimization method for the selection of nanoemulsion composition. … (more)
- Is Part Of:
- Artificial cells, nanomedicine, and biotechnology. Volume 45:Number 3(2017)
- Journal:
- Artificial cells, nanomedicine, and biotechnology
- Issue:
- Volume 45:Number 3(2017)
- Issue Display:
- Volume 45, Issue 3 (2017)
- Year:
- 2017
- Volume:
- 45
- Issue:
- 3
- Issue Sort Value:
- 2017-0045-0003-0000
- Page Start:
- 515
- Page End:
- 521
- Publication Date:
- 2017-04-03
- Subjects:
- Cut and weigh method -- intranasal delivery -- nanoemulsion -- nasal irritancy -- pseudo-ternary phase diagram
Artificial cells -- Periodicals
Nanotechnology -- Periodicals
Blood substitutes -- Periodicals
Tissue engineering -- Periodicals
Molecules -- Periodicals
Biotechnology -- Periodicals
615.39 - Journal URLs:
- http://informahealthcare.com/loi/abb?open=2012#id_2012 ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/21691401.2016.1160405 ↗
- Languages:
- English
- ISSNs:
- 2169-1401
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 575.xml